Search results

Search terms
You searched for:
Found 1,536 results
Sorting options:
 
Date: 01/01/2026 Location: Other
Cardiovascular-kidney-metabolic (CKM) syndrome is defined as a health disorder attributable to connections among obesity, diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). CKM syndrome includes those at risk for CVD and those with existing CVD. The clinical implications of poor CKM health are significant, with potential for premature mortality, excess morbidity, multiorgan disease, and high health care expenditures driven largely by the burden of cardiovascular disease.Managing CKM syndrome typically involves a multidisciplinary approach targeting risk factors such as high blood pressure, high cholesterol, diabetes, and obesity, as well as strategies to preserve kidney function and prevent cardiovascular complications. This may include lifestyle modifications (such as diet and exercise), medications to control blood pressure and blood sugar levels, and sometimes interventions such as dialysis in advanced cases of kidney disease. This webinar will examine the latest findings regarding the diagnosis and treatment of CKM syndrome. It will also provide useful tools and resources for enhancing CVD risk factor management associated with CKM in primary healthcare settings.
1.5 Educational activity hours
  Professionalism
 
Date: 01/01/2026 Location: Other
Approximately 65% of Australians aged 15 and over are overweight or obese. Obesity is a chronic, complex disease linked to various complications, particularly cardiovascular disease (CVD). In 2015, over two-thirds of the 4 million deaths related to high body mass index (BMI) were due to CVD. There are a number of therapies that can help address obesity and reduce CVD, including GLP-1 analogues, bariatric surgery and lifestyle-based therapies.This activity will explore the latest research on glucose-lowering therapies, bariatric surgery, lifestyle-based interventions, and their benefits for managing CVD in overweight and obese individuals. It will provide practical tools and resources for improving CVD risk factor management in primary healthcare settings.
1.5 Educational activity hours
  Professionalism
 
Date: 01/01/2026 Location: Other
Dr Bakr will take students through the complexities of facial and neck anatomy. This interactive course will be delivered by Zoom over a 6 week period, with reinforcement quizzes at the end of each week (delivered by ACAM’s e-skilled platform). This course is suitable for those interested in cosmetic medicine, skin cancer medicine or those who would like to increase their overall knowledge of facial anatomy. On completion of the lecture series and quizzes students will be awarded a certificate of completion.
3.5 Performance review hours
21.5 Educational activity hours
  Culturally safe practice
  Professionalism
 
Date: 01/01/2026 Location: Other
Chronic Kidney Disease (CKD) is a prevalent and under-recognised condition in Australia. By improving screening, prevention, and management of CKD, GPs can provide high-quality care and support for patients with this condition, delay the need for expensive kidney replacement therapies, and improve patient outcomes. Therefore, the detection, diagnosis and management of CKD is a crucial component of general practice. In this audit activity GPs will learn how to identify individuals in their practice at risk of CKD and without a coded diagnosis data extraction tool(e.g. PENCAT or Primary Sense). GPs will implement Kidney Health Checks for identified at risk patients without a coded diagnosis and reflect on any gaps in CKD care for each patient based upon best practice guidelines. Finally, the GP will consider and document options for improvement in the practice systems and in consultations.
3 Educational activity hours
4 Performance review hours
4 Outcome measurement hours
 
Date: 01/01/2026 Location: Other
Cardiovascular disease (CVD) remains a leading cause of death in Australia, yet many general practitioners (GPs) report limited confidence and training in delivering effective nutrition and lifestyle counselling for prevention and management. Although most GPs recognise their vital role and wish to improve their skills, few routinely assess or advise on dietary patterns. At the same time, nearly 60% of Australian adults have low health literacy, making it difficult for patients to understand cardiovascular risk information or act on lifestyle advice. Training that integrates evidence‑based communication and practical counselling strategies can help bridge these gaps. This activity will strengthen GP competence in explaining cardiovascular risk and providing brief, guideline‑aligned advice on nutrition, physical activity, alcohol, and other modifiable behaviours. By improving confidence and communication effectiveness, GPs can better support patients in making sustainable lifestyle changes that reduce CVD risk and improve long‑term health outcomes.
4 Educational activity hours
  Professionalism
  Addressing health inequities
 
Date: 01/01/2026 Location: Other
Colorectal (bowel) cancer (CRC) continues to have considerable burden on Australians, with 97,754 years of healthy life lost due to CRC in 2022. Further to this, the incidence of early-onset colorectal cancer (EOCRC) is increasing globally, with CRC being the deadliest cancer for Australians aged 25 to 44. Approximately 75% of bowel cancers are diagnosed symptomatically. GPs play a key role in managing patient presentations, screening for CRC and referring patients for further investigation. By incorporating the recently-updated NHMRC-endorsed guidelines with existing tools to support quality outcomes, GPs can play a greater role in driving investigations for signs and symptoms potentially associated with CRC.
1 Educational activity hour
4 Outcome measurement hours
4 Performance review hours
  Professionalism
  Ethical practice
 
Date: 01/01/2026 Location: Other
Agitation in dementia is a frequent and distressing symptom encountered by GPs, particularly in residential aged care and community settings. General practitioners may feel ill-equipped to assess the causes of agitation, apply non-pharmacological management, and use psychotropic medications safely and appropriately. This webinar, delivered by expert medical educators from Dementia Training Australia,explores the care of an agitated person living with dementia.
1 Educational activity hour
  Professionalism
  Ethical practice
 
Date: 01/01/2026 Location: Other
This webinar will provide General Practitioners with a practical understanding of the emerging role of pharmacogenomics (PGx) in clinical practice. Associate Professor Kym Mina, a Genetic Pathologist, will introduce the fundamentals of PGx - what it is, how it works, the supporting science, and an overview of current Australian and international clinical guidelines. GP Dr Stuart Arbuckle will then present two clinical case studies demonstrating the practical application of PGx in mental health. The goal is to improve patient outcomes, enhance compliance, and reduce adverse effects.The webinar will conclude with an interactive Qandamp;A panel session, offering attendees a chance to engage in a clinical discussion and have their specific questions answered. The session will equip attendees with the knowledge to begin incorporating PGx testing into their everyday practice to offer a more personalised approach to medicine.
1 Educational activity hour
  Professionalism
 
Date: 01/01/2026 Location: Other
This webinar is the second in a four-part series on ESUS and the importance of patent foramen ovale in ESUS aetiology and management.This activity aims to: • Outline the basics of patent foramen ovale and how it relates to ESUS/cryptogenic stroke • Describe the landscape of ESUS and PFO in the Australian population including incidence of ESUS and prevalence of PFO • Discuss the clinical presentations of ESUS • List the diagnostic evaluation required for detection and treatment in PFO-related stroke including the bubble test and transcranial doppler study
1 Educational activity hour
 
Date: 01/01/2026 Location: Other
This webinar is the first in a four-part series on ESUS and the importance of patent foramen ovale in ESUS aetiology and management. It will set the scene for this education by:Providing an overview of “traditional” stroke classifications, pathophysiology, and epidemiologyA review of guidelines on both primary and secondary prevention in stroke managementThe relevance of ESUS in stroke will then be presented by:Outlining how ESUS/cryptogenic stroke fits within the broader topic/diagnosis of strokeHow ESUS does not always fit with the risk and management paradigm of non-ESUS stroke
1 Educational activity hour